Ýmis lyf 80 Æxlishemjandi lyf
Awarded
The competition has ended and a winner has been selected.
Farmasøytisk engroshandel
Landspítali Háskólasjúkrahús has entered into a framework agreement with Icepharma, Vistor, Alvogen ehf, Williams & Halls ehf, and Icepharma Pfizer for the delivery of various pharmaceutical products, specifically antineoplastic drugs, to the Capital Region of Iceland. The agreement has a duration of 2 years and a maximum total value of 13.8 billion Icelandic Króna. The award was based on quality, and 29 bids were received.
Result
- Winners
- Alvogen ehf
- Icepharma
- Icepharma
- Icepharma Pfizer
- Vistor
- Williams & Halls ehf
- Other bidders
- Acare ehf
- Artasan
- Teva Pharma Iceland ehf
- Contract value
- ISK 0
- Maximum framework agreement value
- Up to ISK 13,800,000,000
About the bid
- Contact name
- Ragnar Davíðsson
- Contact phone
- 3548245276
- Contact email
- ragnard@landspitali.is
- Address
- Skaftahlid 24, 105 Reykjavík
Landspítali University hospital calls for tender for various drugs. Further description is in the Tender Documents available electronically from the Mercell Tendsign procurement portal.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
Se anbudsdokumenter for detaljer.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Landspítali Háskólasjúkrahús
- Title
- Ýmis lyf 80 Æxlishemjandi lyf
- Type
- Main code
- Supplemental codes
- Location
- Höfuðborgarsvæði
- Estimated value
- ISK 13,800,000,000
- Duration
- 2 years
No supplemental codes from buyer…